National Breast Cancer Coalition

Call to Action March 2018

The Artemis® Project 

Earlier this month, NBCC held its annual Artemis meeting, bringing together advocates and those with scientific expertise ranging from immunology, biophysics, and genetics, to molecular biology and clinical oncology.  The Artemis® Project has launched a number of effective collaborations among diverse researchers and advocates. Project participants continue to focus on primary prevention and the prevention of metastasis. Much of the discussion during the meeting brought immunology and genomics to the forefront of Artemis priorities. The Artemis® Project continues to rely on an innovative model of cooperation, in which individuals are aligned toward the common goal of ending breast cancer and interact and engage with others with complementary talents, skills, and expertise.

Team Leader Training

NBCC held Team Leader Training on March 18th and 19th. Breast cancer advocates from around the country traveled to Washington, D.C. for an intensive two-day training on NBCC's 2018 legislative and public policy priorities, the legislative process, and lobbying best practices. Following the preparation and training activities, Team Leaders spread across Capitol Hill, held more than 80 meetings with senators, representatives and staffers to discuss and forward the NBCC legislative and public policy agenda.


On February 28th, NBCC hosted Dr. Premal Patel as he presented Immunotherapy and CAR-T: A Decade of Progress in the Clinic. CAR-cell therapy has shown success in treating blood cancers, but what about breast cancer? Dr. Patel spoke about the advances in the field of immunotherapy and breast cancer trials.

Premal Patel, MD, PhD is the Senior Vice President of Early Clinical Development at Juno Therapeutics, Inc. His focus is on developing cell-based cancer immunotherapies based on chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer.

On March 15th, Dr. Peter Lee presented: Tumor Draining Lymph Nodes and Biologic Behavior. There is a complex interplay between immune/stromal cells and cancer cells within tumors, tumor-draining lymph nodes (TDLNs), and blood. Dr. Lee spoke about the functions of the TDLNs and their significance in breast cancer.  

Peter P. Lee, MD is a Billy and Audrey L. Wilder Endowed Professor and Chair in the Department of Cancer Immunotherapeutics & Tumor Immunology (CITI) at the City of Hope Comprehensive Cancer Center. His research focuses on how breast cancer impacts host immune responses in patients.

Are you interested in these issues? Become a Project LEAD® graduate!

NBCC's 2018 Project LEAD® Institute

The application window for the 2018 Project LEAD® Institute is now open!

The Project LEAD® Institute is a six-day training program for advocates interested in the science of breast cancer, and will cover the basics of cancer biology, genetics, epidemiology, research design, and advocacy. Taught by renowned scientific faculty, the Institute will be held Sunday, July 22nd - Friday, July 27th at the Estancia La Jolla Hotel in La Jolla, California. 

Project LEAD® graduates:
1. Share correct, evidence-based information on breast cancer with their communities; and
2. Work with researchers, scientists, and leaders to design and promote breast cancer research priorities.

There is no charge for this program.  Applicants can also apply for need-based scholarships to assist with lodging and travel expenses.

Application Deadline: April 18th, 2018
Notification of Acceptance: June 1st, 2018

Questions? Please email

Public Policy

Breast cancer is a political issue. It is essential that those who influence breast cancer policy are not only well-educated and trained but also have no agenda other than saving lives. Each year, NBCC’s grassroots Board of Directors, with input from our membership, determines our public policy and legislative priorities for the coming year.  The 2018 priorities are available here.

Spread the word and be prepared for the action alerts from NBCC to make these priorities a reality! Attend the annual Summit & Lobby Day!

2018 Advocate Leadership Summit & Lobby Day

This is a critical moment in our mission to know how to end breast cancer. Now is the time when we must build on the considerable strengths of leaders and visionaries who are working at every level to achieve our mission to end breast cancer and Breast Cancer Deadline 2020®.   We need advocates like you to help carry the mission forward and ensure that the educated and trained patient voice is heard everywhere that decisions about breast cancer are made.

Become an expert Advocate Leader and attend the NBCC Advocate Leadership Summit April 28 - May 1, 2018 in Washington, D.C. Session's at this year's Summit include:

  • Building a Local Advocacy Network: How do you build an advocacy network that isn’t a virtual social media group? Join a discussion with people who have built effective local advocacy groups. Share your current challenges, hear others’ successful strategies, and develop your own network expansion plan.          
  • Immunotherapy and Breast Cancer: What’s Happening? 
  • How to Use Social Media for Advocacy: Social Media can provide tremendous rewards if you are creative and persistent. Learn the basics of using social media, how you can leverage social media for advocacy and how to create a strategy for using social media as part of your advocacy efforts.                
  • The Artemis® Project: Where are we with the preventative vaccine? What work is being done in prevention of metastasis?
  • Participating Effectively in a Scientific Peer Review: What is involved in the scientific review process? What is the critical role of the advocate? Learn from advocates and an expert in scientific review and prepare to become involved! 

We can achieve our mission to end breast cancer. But we will only get there with the relentless advocacy of well-trained leaders like you.  Register today to take action and inspire your fellow advocates.

*** The hotel reservation deadline is April 6, 2018. ***

Women with Balls: DC

What: NBCC’s Annual Women With Balls® Bowling Challenge
When: Monday, April 30th, 6:30 p.m. to 9:30 p.m.
Where: Lucky Strike at Gallery Place, 701 7th St. NW, 202-347-1021 

Bowler: Show us what you got! Raise a minimum of $500. All you can bowl, eat, and drink. Exciting prizes awarded.
Cheerleader: Raise a minimum of $250
. We'll spare you the bowling. Eat, drink, and compete for Best Cheerleader prize.
Women with Balls® shirts will be provided to all participants.

Raise funds through a Deadline Champion fundraising page and you are on a roll! Space is limited so sign up today! RSVP to Sharnita Goins at or by phone at 202-973-0569.

NBCC statement on direct-to-consumer genetic testing

On March 6th, the U.S. Food and Drug Administration (FDA) announced approval of a direct-to-consumer genetic test for BRCA mutations, which have been linked to an increased risk of breast, ovarian, and prostate cancer.  NBCC is concerned about the limitations and implications of direct-to-consumer genetic testing for breast cancer and believes it is irresponsible to market and promote its widespread use at this time. To read NBCC's entire statement, click here

DOD BCRP Funding Update

Urge your senators to sign the Department of Defense Breast Cancer Research Program Letter Today! The deadline for your Senators to sign is Thursday, March 29th. Our grassroots supporters must take action to urge their Senators to sign the letter! 

Contact your Senators and ask them to sign the DOD Breast Cancer Research Program letterThis is the list of who signed last year; if your Senator(s) are on the list, thank them and ask them to sign again. If your Senator(s) are not on the list, ask them to sign on this year. 

Charity Auction Alert

The most stylish name in home furnishings wants to make your home a more comfortable place! Bid on a $2,500 gift card to Mitchell Gold + Bob Williams and support NBCC's mission to know how to end breast cancer. Go here and bid today!

Help Us End Breast Cancer

When we set a deadline to know how to end breast cancer, we knew it would be difficult to achieve and controversial to try. But we are well on our way, and that is in large part because of you. With your help, we can achieve our mission to end breast cancer. Thank you for considering a gift in support of Breast Cancer Deadline 2020®. Please donate online.